Calcium channel blockers and beta-blockers versus beta-blockers alone for preventing exercise-induced arrhythmias in catecholaminergic polymorphic ventricular …

R Rosso, JM Kalman, O Rogowski, S Diamant, A Birger… - Heart Rhythm, 2007 - Elsevier
BACKGROUND: The mainstay of therapy for catecholaminergic polymorphic ventricular
tachycardia (CPVT) is maximal doses of β-blockers. However, although β-blockers prevent …

Calcium channel blockers and beta-blockers versus beta-blockers alone for preventing exercise-induced arrhythmias in catecholaminergic polymorphic ventricular …

R Rosso, JM Kalman, O Rogowski, S Diamant, A Birger… - Heart Rhythm, 2007 - infona.pl
The mainstay of therapy for catecholaminergic polymorphic ventricular tachycardia (CPVT)
is maximal doses of β-blockers. However, although β-blockers prevent exercise-induced …

Calcium channel blockers and beta-blockers versus beta-blockers alone for preventing exercise-induced arrhythmias in catecholaminergic polymorphic ventricular …

R Rosso, JM Kalman, O Rogowski, S Diamant… - Heart Rhythm, 2007 - europepmc.org
Background The mainstay of therapy for catecholaminergic polymorphic ventricular
tachycardia (CPVT) is maximal doses of beta-blockers. However, although beta-blockers …

Calcium channel blockers and beta-blockers versus beta-blockers alone for preventing exercise-induced arrhythmias in catecholaminergic polymorphic ventricular …

R Rosso, JM Kalman, O Rogowski, S Diamant… - Heart Rhythm, 2007 - hero.epa.gov
BACKGROUND The mainstay of therapy for catecholaminergic polymorphic ventricular
tachycardia (CPVT) is maximal doses of beta-blockers. However, although beta-blockers …

[引用][C] Calcium channel blockers and beta-blockers versus beta-blockers alone for preventing exercise-induced arrhythmias in catecholaminergic polymorphic …

R ROSSO - Heart Rhythm, 2007 - cir.nii.ac.jp
Calcium channel blockers and beta-blockers versus beta-blockers alone for preventing
exercise-induced arrhythmias in catecholaminergic polymorphic ventricular tachycardia | CiNii …

Calcium channel blockers and beta-blockers versus beta-blockers alone for preventing exercise-induced arrhythmias in catecholaminergic polymorphic ventricular …

R Rosso, JM Kalman, O Rogowski… - Heart …, 2007 - pubmed.ncbi.nlm.nih.gov
Background The mainstay of therapy for catecholaminergic polymorphic ventricular
tachycardia (CPVT) is maximal doses of beta-blockers. However, although beta-blockers …

Calcium channel blockers and beta-blockers versus beta-blockers alone for preventing exercise-induced arrhythmias in catecholaminergic polymorphic ventricular …

R Rosso, JM Kalman, O Rogowski, S Diamant… - Heart …, 2007 - heartrhythmjournal.com
Background The mainstay of therapy for catecholaminergic polymorphic ventricular
tachycardia (CPVT) is maximal doses of β-blockers. However, although β-blockers prevent …

[PDF][PDF] Calcium channel blockers and beta-blockers versus beta-blockers alone for preventing exercise-induced arrhythmias in catecholaminergic polymorphic …

R Rosso, JM Kalman, O Rogowski, S Diamant… - Heart Rhythm, 2007 - academia.edu
BACKGROUND The mainstay of therapy for catecholaminergic polymorphic ventricular
tachycardia (CPVT) is maximal doses of ß-blockers. However, although ß-blockers prevent …

[引用][C] Calcium channel blockers and beta-blockers versus beta-blockers alone for preventing exercise-induced arrhythmias in catecholaminergic polymorphic …

R Rosso, JM Kalman, O Rogowski, S Diamant, A Birger… - Heart Rhythm, 2007 - cir.nii.ac.jp
Calcium channel blockers and beta-blockers versus beta-blockers alone for preventing
exercise-induced arrhythmias in catecholaminergic polymorphic ventricular tachycardia | CiNii …